Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome

Objective:Elevated liver function tests (LFTs) are common in adult Turner syndrome (TS) patients. Data regarding children and adolescents are lacking. To investigate the prevalence of abnormal LFTs in children and adolescents with TS during several years of observation; to evaluate the potential imp...

Full description

Bibliographic Details
Main Authors: Małgorzata Wójcik, Anna Ruszała, Dominika Januś, Jerzy B. Starzyk
Format: Article
Language:English
Published: Galenos Yayincilik 2019-12-01
Series:JCRPE
Subjects:
Online Access: http://www.jcrpe.org/archives/archive-detail/article-preview/liver-biochemical-abnormalities-in-adolescent-pati/27600
_version_ 1797923453547839488
author Małgorzata Wójcik
Anna Ruszała
Dominika Januś
Jerzy B. Starzyk
author_facet Małgorzata Wójcik
Anna Ruszała
Dominika Januś
Jerzy B. Starzyk
author_sort Małgorzata Wójcik
collection DOAJ
description Objective:Elevated liver function tests (LFTs) are common in adult Turner syndrome (TS) patients. Data regarding children and adolescents are lacking. To investigate the prevalence of abnormal LFTs in children and adolescents with TS during several years of observation; to evaluate the potential impact of increased body mass index (BMI) and sex hormone replacement therapy (HRT) on LFTs.Methods:The analysis included 100 girls with TS, aged 4-16 years, all of whom were receiving recombinant human growth hormone therapy. A longitudinal study was conducted which included 81 patients.Results:Mean BMI-standard deviation (SD) score of the subjects was 0.63 (SD: 1.53). Forty-four were being treated with HRT. Elevated LFTs were found in 34% of the patients overall (32% not receiving HRT vs 36% on HRT). The relative risk of increased LFTs was not higher in obese vs normal weight [odds ratio (OR): 0.2; 95% confidence interval (CI): 0.1-0.36, p=0.38 vs OR: 0.16; 95% CI: 0.08-0.3, p=0.1]. HRT did not increase the risk of abnormal LFTs activity (OR: 0.8; 95% CI: 0.5-1.2, p=0.37 vs OR: 0.7; 95% CI: 0.4-1.1, p=0.27). During the follow-up period (mean±SD=4.31±0.82 years), no patient developed overt liver disease. There was no significant increase nor decrease of abnormal LFT frequency in the subsequent years of follow up.Conclusion:Constantly elevated LFTs in TS are common in children and adolescents with TS. However the causes and clinical significance remain unclear. This study suggests that obesity and HRT do not increase the risk of elevated LFTs.
first_indexed 2024-04-10T14:46:32Z
format Article
id doaj.art-1ad95052708c43fabf56d98ab798bd32
institution Directory Open Access Journal
issn 1308-5727
1308-5735
language English
last_indexed 2024-04-10T14:46:32Z
publishDate 2019-12-01
publisher Galenos Yayincilik
record_format Article
series JCRPE
spelling doaj.art-1ad95052708c43fabf56d98ab798bd322023-02-15T16:07:47ZengGalenos YayincilikJCRPE1308-57271308-57352019-12-0111439539910.4274/jcrpe.galenos.2019.2018.027113049054Liver Biochemical Abnormalities in Adolescent Patients with Turner SyndromeMałgorzata Wójcik0Anna Ruszała1Dominika Januś2Jerzy B. Starzyk3 Jagiellonian University Medical College, Pediatric Institute, Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics; Children’s University Hospital, Kraków, Poland Jagiellonian University Medical College, Pediatric Institute, Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics; Children’s University Hospital, Kraków, Poland Jagiellonian University Medical College, Pediatric Institute, Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics; Children’s University Hospital, Kraków, Poland Jagiellonian University Medical College, Pediatric Institute, Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics; Children’s University Hospital, Kraków, Poland Objective:Elevated liver function tests (LFTs) are common in adult Turner syndrome (TS) patients. Data regarding children and adolescents are lacking. To investigate the prevalence of abnormal LFTs in children and adolescents with TS during several years of observation; to evaluate the potential impact of increased body mass index (BMI) and sex hormone replacement therapy (HRT) on LFTs.Methods:The analysis included 100 girls with TS, aged 4-16 years, all of whom were receiving recombinant human growth hormone therapy. A longitudinal study was conducted which included 81 patients.Results:Mean BMI-standard deviation (SD) score of the subjects was 0.63 (SD: 1.53). Forty-four were being treated with HRT. Elevated LFTs were found in 34% of the patients overall (32% not receiving HRT vs 36% on HRT). The relative risk of increased LFTs was not higher in obese vs normal weight [odds ratio (OR): 0.2; 95% confidence interval (CI): 0.1-0.36, p=0.38 vs OR: 0.16; 95% CI: 0.08-0.3, p=0.1]. HRT did not increase the risk of abnormal LFTs activity (OR: 0.8; 95% CI: 0.5-1.2, p=0.37 vs OR: 0.7; 95% CI: 0.4-1.1, p=0.27). During the follow-up period (mean±SD=4.31±0.82 years), no patient developed overt liver disease. There was no significant increase nor decrease of abnormal LFT frequency in the subsequent years of follow up.Conclusion:Constantly elevated LFTs in TS are common in children and adolescents with TS. However the causes and clinical significance remain unclear. This study suggests that obesity and HRT do not increase the risk of elevated LFTs. http://www.jcrpe.org/archives/archive-detail/article-preview/liver-biochemical-abnormalities-in-adolescent-pati/27600 turner syndromechildrenliverestrogen
spellingShingle Małgorzata Wójcik
Anna Ruszała
Dominika Januś
Jerzy B. Starzyk
Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome
JCRPE
turner syndrome
children
liver
estrogen
title Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome
title_full Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome
title_fullStr Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome
title_full_unstemmed Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome
title_short Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome
title_sort liver biochemical abnormalities in adolescent patients with turner syndrome
topic turner syndrome
children
liver
estrogen
url http://www.jcrpe.org/archives/archive-detail/article-preview/liver-biochemical-abnormalities-in-adolescent-pati/27600
work_keys_str_mv AT małgorzatawojcik liverbiochemicalabnormalitiesinadolescentpatientswithturnersyndrome
AT annaruszała liverbiochemicalabnormalitiesinadolescentpatientswithturnersyndrome
AT dominikajanus liverbiochemicalabnormalitiesinadolescentpatientswithturnersyndrome
AT jerzybstarzyk liverbiochemicalabnormalitiesinadolescentpatientswithturnersyndrome